Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction.
Mercadante
S
S
D000328:Adult; D002086:Butylscopolammonium Bromide / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005770:Gastrointestinal Neoplasms / Q000150:complications / Q000503:physiopathology; D006801:Humans; D007415:Intestinal Obstruction / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy
D005765:Gastrointestinal Agents; D018727:Muscarinic Antagonists; D002086:Butylscopolammonium Bromide; D015282:Octreotide